Disease on EC 2.6.1.5 - tyrosine transaminase
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Arthritis, Experimental
The influence of antagonists of poly(ADP-ribose)polymerase on the activity of antirheumatic drugs on the development of adjuvant arthritis in rats and on the induction of tyrosine aminotransferase in the liver of rats.
Brain Ischemia
Analysis of serum metabolites for the discovery of amino acid biomarkers and the effect of galangin on cerebral ischemia.
Carcinoma 256, Walker
Changes in liver tyrosine-alpha-ketoglutarate transaminase activity during growth of Walker carcinosarcoma 256.
Carcinoma, Hepatocellular
"Superinduction" of tyrosine aminotransferase by actinomycin D: a reevaluation.
Carcinoma, Hepatocellular
"Superinduction" of tyrosine transaminase in hepatoma cell cultures: differential inhibition of synthesis and turnover by actionomycin D.
Carcinoma, Hepatocellular
5alpha-reduced glucocorticoids, novel endogenous activators of the glucocorticoid receptor.
Carcinoma, Hepatocellular
A genetic analysis of extinction: trans-dominant loci regulate expression of liver-specific traits in hepatoma hybrid cells.
Carcinoma, Hepatocellular
A histochemical method for the demonstration of tyrosine aminotransferase in tissue culture cells, and studies of this enzyme in hepatoma tissue culture cells.
Carcinoma, Hepatocellular
A new glucocorticoid receptor detected in host rat liver but not in various hepatomas.
Carcinoma, Hepatocellular
A post-transcriptional site of induction of tyrosine aminotransferase by dexamethasone in Reuber H35 hepatoma cells.
Carcinoma, Hepatocellular
Activity of protein kinase dependent on adenosine 3':5'-monophosphate and of its thermostable protein inhibitor in rat hepatoma (HTC) cells. Unlikely role in the permissive action of glucocorticoids.
Carcinoma, Hepatocellular
Alteration of tyrosine aminotransferase activity in hepatoma cells in tissue culture by amphotericin B.
Carcinoma, Hepatocellular
Amino acid transport in hepatoma cell cultures during tyrosine aminotransferase induction.
Carcinoma, Hepatocellular
Analysis of insulin action using differentiated and dedifferentiated hepatoma cells.
Carcinoma, Hepatocellular
Analysis of the induction and deinduction of tyrosine aminotransferase in enucleated HTC cells.
Carcinoma, Hepatocellular
Analysis of the relation between receptor binding affinity and antagonist efficacy of antiglucocorticoids.
Carcinoma, Hepatocellular
Antiglucocorticoid steroids have increased agonist activity in those hepatoma cell lines that are more sensitive to glucocorticoids.
Carcinoma, Hepatocellular
Arsenic at very low concentrations alters glucocorticoid receptor (GR)-mediated gene activation but not GR-mediated gene repression: complex dose-response effects are closely correlated with levels of activated GR and require a functional GR DNA binding domain.
Carcinoma, Hepatocellular
Aryl hydrocarcon hydroxylase and tyrosine aminotransferase activities in somatic-cell hybrids derived from hepatoma tissue culture HTC (rat) cells and 3T3 (mouse) benzo(a)pyrene-resistant cells.
Carcinoma, Hepatocellular
Binding of glucocorticoid antagonists to androgen and glucocorticoid hormone receptors in rat skeletal muscle.
Carcinoma, Hepatocellular
Cell-cycle regulation of insulin-stimulated tyrosine aminotransferase activity in rat hepatoma cells.
Carcinoma, Hepatocellular
Chromosomal assignment and trans regulation of the tyrosine aminotransferase structural gene in hepatoma hybrid cells.
Carcinoma, Hepatocellular
Concanavalin A alters the turnover rate of tyrosine aminotransferase in cultured hepatoma cells.
Carcinoma, Hepatocellular
Constancy of expression of the protein kinase A regulatory subunit R1 alpha in hepatoma cell lines of different phenotypes.
Carcinoma, Hepatocellular
Control of degradation and synthesis of induced tyrosine aminotransferase studied in hepatoma cells in culture.
Carcinoma, Hepatocellular
Correlation between different gene expression assays designed to measure trans-activation potencies of systemic glucocorticoids.
Carcinoma, Hepatocellular
Cyclic adenonosine monophosphate does not affect the stability of the messenger ribonucleic acid for tyrosine aminotransferase in cultured hepatoma cells.
Carcinoma, Hepatocellular
Cytokines and the activity of tyrosine aminotransferase and superoxide dismutase in rat hepatoma cells in culture.
Carcinoma, Hepatocellular
Description and analysis of differential sensitivity to glucocorticoids in Fao cells.
Carcinoma, Hepatocellular
Dexamethasone phosphate-induced synthesis of tyrosine aminotransferase in hepatoma tissue culture cells. Studies of the early phases of induction and of the steroid requirement for maintanance of the induced rate of synthesis.
Carcinoma, Hepatocellular
Differences in rates of tyrosine aminotransferase deinduction with cyclic AMP and glucocorticoids.
Carcinoma, Hepatocellular
Differences in the mode of regulation of ornithine decarboxylase and tyrosine aminotransferase in H-35 rat hepatoma cells shown by varying the medium composition.
Carcinoma, Hepatocellular
Differential activity of a tissue-specific extinguisher locus in hepatic and nonhepatic cells.
Carcinoma, Hepatocellular
Differential effects of N-methyl-N'-nitro-N-nitrosoguanidine on constitutive and hormone-inducible gene expression in rat hepatoma cells.
Carcinoma, Hepatocellular
Differential modulation of gene induction by glucocorticoids and antiglucocorticoids in rat hepatoma tissue culture cells.
Carcinoma, Hepatocellular
Differential recruitment of glucocorticoid receptor phospho-isoforms to glucocorticoid-induced genes.
Carcinoma, Hepatocellular
Differential sensitivity of HTC and Fu5-5 cells for induction of tyrosine aminotransferase by 3',5'-cyclic adenosine monophosphate.
Carcinoma, Hepatocellular
Direct evidence that the protein kinase catalytic subunit mediates the effects of cAMP on tyrosine aminotransferase synthesis.
Carcinoma, Hepatocellular
Dose-dependent regulation of superoxide anion on the proliferation, differentiation, apoptosis and necrosis of human hepatoma cells: the role of intracellular Ca 2+.
Carcinoma, Hepatocellular
Down-regulation of tyrosine aminotransferase at a frequently deleted region 16q22 contributes to the pathogenesis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Effect of B6 deficiency on hepatoma 7794A growth rate: activities of tyrosine transaminase and serine dehydratase before and after induction by hydrocortisone.
Carcinoma, Hepatocellular
Effect of concanavalin A on tyrosine aminotransferase in rat hepatoma tissue culture cells. Rapid reversible inactivation of soluble enzyme.
Carcinoma, Hepatocellular
Effect of cordycepin on induction of tyrosine aminotransferase employing hepatoma cells in tissue culture.
Carcinoma, Hepatocellular
Effect of inhibitors of nucleic acid synthesis on steroid-mediated induction of tyrosine aminotransferase in hepatoma cell cultures.
Carcinoma, Hepatocellular
Effect of phenobarbital on the glucocorticoid receptor in rat hepatoma cells.
Carcinoma, Hepatocellular
Effect of potent antiglucocorticoids on dexamethasone induced enzymes in cultured hepatoma and rat liver cells.
Carcinoma, Hepatocellular
Effect of pyridoxine deficiency on tyrosine transaminase activity and growth of four Morris hepatomas.
Carcinoma, Hepatocellular
Effect of pyridoxine on the growth of Morris hepatoma No. 7288Ctc and enzyme activity.
Carcinoma, Hepatocellular
Effects of 6- and 8-substituted analogs of adenosine 3':5'-monophosphate on phosphoenolpyruvate carboxykinase and tyrosine aminotransferase in hepatoma cell cultures.
Carcinoma, Hepatocellular
Effects of dietary vitamin B6 on the in vitro inactivation of rat tyrosine aminotransferase in host liver and Morris hepatomas.
Carcinoma, Hepatocellular
Effects of exogenous histones upon the induction of tryptophan pyrrolase and tyrosine transaminase in liver and Morris hepatomas.
Carcinoma, Hepatocellular
Enzyme induction and receptor-binding affinity of steroidal 20-carboxamides in rat hepatoma tissue culture cells.
Carcinoma, Hepatocellular
Epidermal growth factor inhibits phosphoenolpyruvate carboxykinase gene expression in rat hepatocytes in primary culture.
Carcinoma, Hepatocellular
Establishment of a clonal strain of hepatoma cells derived from Morris hepatoma 8999.
Carcinoma, Hepatocellular
Explanation for the apparent inactivation of tyrosine aminotransferase in hepatoma cells by concanavalin A.
Carcinoma, Hepatocellular
Expression and amplification of cloned rat liver tyrosine aminotransferase in nonhepatic cells.
Carcinoma, Hepatocellular
Expression of differentiated functions in hepatoma cell hybrids. I. Tyrosine aminotransferase in hepatoma-fibroblast hybrids.
Carcinoma, Hepatocellular
Expression of differentiated functions in hepatoma cell hybrids: reappearance of tyrosine aminotransferase inducibility after the loss of chromosomes.
Carcinoma, Hepatocellular
Expression of hormonally induced tyrosine transaminase in normal, host liver and three Morris hepatomas.
Carcinoma, Hepatocellular
Further evidence against post-transcriptional control of inducible tyrosine aminotransferase synthesis in cultured hepatoma cells.
Carcinoma, Hepatocellular
Further evidence for posttranscriptional control of inducible tyrosine aminotransferase synthesis in cultured hepatoma cells.
Carcinoma, Hepatocellular
Further evidence for translational regulation of tyrosine aminotransferase synthesis by dibutyryl cyclic AMP in Reuber H35 hepatoma cells.
Carcinoma, Hepatocellular
Genetic activity of a trans-regulatory locus in hepatoma hybrid cells.
Carcinoma, Hepatocellular
Glucagon resistance of hepatoma cells. Evidence for receptor and post-receptor defects.
Carcinoma, Hepatocellular
Glucocorticoid receptors in hepatocellular carcinoma and adjacent liver tissue.
Carcinoma, Hepatocellular
Glucocorticoids locally disrupt an array of positioned nucleosomes on the rat tyrosine aminotransferase promoter in hepatoma cells.
Carcinoma, Hepatocellular
Hormonal induction of tyrosine aminotransferase activity in host liver and hepatoma no. 7777 of normal and cofactor-depleted animals.
Carcinoma, Hepatocellular
In vivo protein-DNA interactions in a glucocorticoid response element require the presence of the hormone.
Carcinoma, Hepatocellular
Increased turnover of the messenger RNA encoding tyrosine aminotransferase can account for the desensitization and de-induction of tyrosine aminotransferase by 8-bromo-cyclic AMP treatment and removal.
Carcinoma, Hepatocellular
Induction of aryl hydrocarbon (benzo(a)pyrene) hydroxylase and tyrosine aminotransferase in hepatoma cells in culture.
Carcinoma, Hepatocellular
Induction of tyrosine aminotransferase activity by concanavalin A in cultured rat hepatoma cells.
Carcinoma, Hepatocellular
Induction of tyrosine aminotransferase and amino acid transport in Morris hepatomas and in adult and neonatal rat liver.
Carcinoma, Hepatocellular
Induction of tyrosine aminotransferase and amino acid transport in rat hepatoma cells by insulin and the insulin-like growth factor, multiplication-stimulating activity. Mediation by insulin and multiplication-stimulating activity receptors.
Carcinoma, Hepatocellular
Induction of tyrosine aminotransferase by D-glucosamine in rat hepatoma cell culture.
Carcinoma, Hepatocellular
Induction of tyrosine aminotransferase by dibutyryl cyclic-AMP employing hepatoma cells in tissue culture.
Carcinoma, Hepatocellular
Induction of tyrosine aminotransferase by dibutyryl cyclic-AMP in synchronized hepatoma cells.
Carcinoma, Hepatocellular
Induction of tyrosine aminotransferase in H-35 hepatoma cells by cAMP captured in phospholipid vesicles.
Carcinoma, Hepatocellular
Inhibition by ultraviolet irradiation of the glucocorticoid induction of tyrosine aminotransferase in bromodeoxyuridine-treated H-35 hepatoma.
Carcinoma, Hepatocellular
Inhibition of steroid inducible tyrosine aminotransferase by mouse and rat interferon in hepatoma tissue culture cells.
Carcinoma, Hepatocellular
Inhibition of steroid-inducible tyrosine aminotransferase gene expression by N-methyl-N'-nitro-N-nitrosoguanidine in a rat hepatoma cell line.
Carcinoma, Hepatocellular
Inhibition of tyrosine aminotransferase induction by UTP deficiency and its reversal by 5-fluorouridine in cultured hepatoma cells.
Carcinoma, Hepatocellular
Insulin induction of tyrosine aminotransferase in synchronized hepatoma cells.
Carcinoma, Hepatocellular
Insulin-mediated inhibition of the induction of tyrosine aminotransferase by dexamethasone.
Carcinoma, Hepatocellular
Insulin-mediated regulation of tyrosine aminotransferase in rat hepatoma cells: inhibition of transcription and inhibition of enzyme degradation.
Carcinoma, Hepatocellular
Interaction of glucocorticoid hormones and cyclic nucleotides in induction of tyrosine aminotransferase in cultured hepatoma cells.
Carcinoma, Hepatocellular
Interaction of trans-acting factors and re-expression of liver functions in hepatoma hybrid cells.
Carcinoma, Hepatocellular
Interconversion of multiple forms of tyrosine aminotransferase in vitro and in vivo in cultured hepatoma cells.
Carcinoma, Hepatocellular
Inverse correlation between cyclic GMP and tyrosine aminotransferase degradation in rat hepatoma tissue culture cells.
Carcinoma, Hepatocellular
Inverse correlation between dexamethasone 21-mesylate agonist activity and sensitivity to dexamethasone for induction of tyrosine aminotransferase in rat hepatoma cells.
Carcinoma, Hepatocellular
Ketoconazole inhibition and glucocorticoid action in the human lymphoblastic leukemia cell line CEM-C7.
Carcinoma, Hepatocellular
Kinetics of steroid induction and deinduction of tyrosine aminotransferase synthesis in cultured hepatoma cells.
Carcinoma, Hepatocellular
Lead may affect glucocorticoid signal transduction in cultured hepatoma cells through inhibition of protein kinase C.
Carcinoma, Hepatocellular
Lectins mimic insulin in the induction of tyrosine aminotransferase.
Carcinoma, Hepatocellular
Lipid peroxidation and activities of tyrosine aminotransferase and glutamine synthetase in hepatoma and glioma cells grown in bovine colostrum-supplemented medium.
Carcinoma, Hepatocellular
Loss of reciprocal modulations of growth and liver function of hepatoma cells in culture by contact with cells or cell membranes.
Carcinoma, Hepatocellular
Metabolism and antiproliferative effect of the glucocorticoid antagonist RU38486 in cultured liver and hepatoma cells.
Carcinoma, Hepatocellular
Modulation of glucocorticoid induction of stably transfected tyrosine aminotransferase gene constructs involves elements up-stream of the glucocorticoid-responsive element.
Carcinoma, Hepatocellular
Modulation of glucocorticoid induction of tyrosine aminotransferase gene expression by variations in cell density.
Carcinoma, Hepatocellular
Modulation of hormonal induction of tyrosine aminotransferase and glucocorticoid receptors by aflatoxin B1 and sterigmatocystin in Reuber hepatoma cells.
Carcinoma, Hepatocellular
Modulation of the agonist activity of antisteroids by a novel cis-acting element.
Carcinoma, Hepatocellular
Modulation of transcription factor activity by a distant steroid modulatory element.
Carcinoma, Hepatocellular
Naturally occurring and induced levels of amino acid transport and tyrosine aminotransferase in rats bearing Morris hepatomas.
Carcinoma, Hepatocellular
New steroidal anti-inflammatory antedrugs: methyl 21-desoxy-21-chloro-11beta,17alpha-dihydroxy-3,20-dioxo-1, 4-pregnadiene-16alpha-carboxylate, methyl 21-desoxy-21-chloro-11beta-hydroxy-3,20-dioxo-1, 4-pregnadiene-16alpha-carboxylate, and their 9alpha-fluoro derivatives*.
Carcinoma, Hepatocellular
Normal and stable transfected cancer cell lines: tools for a screening of progestogenic, antiprogestogenic and antiglucocorticoid substances.
Carcinoma, Hepatocellular
Nucleus-dependent regulation of tyrosine aminotransferase degradation in hepatoma tissue culture cells.
Carcinoma, Hepatocellular
On the steroid requirement for induction of tyrosine aminotransferase by N6, O2'-dibutyryl cyclic AMP in hepatoma cells.
Carcinoma, Hepatocellular
Oncogene mediated repression of glucocorticoid hormone response elements and glucocorticoid receptor levels.
Carcinoma, Hepatocellular
Phosphorylation of CREB affects its binding to high and low affinity sites: implications for cAMP induced gene transcription.
Carcinoma, Hepatocellular
Physical properties, limited proteolysis, and acetylation of tyrosine aminotransferase from rat liver.
Carcinoma, Hepatocellular
Positive and negative cAMP-mediated control of tyrosine aminotransferase synthesis in Reuber H35 hepatoma cells.
Carcinoma, Hepatocellular
Preferential inhibition by 5-bromodeoxyuridine of the synthesis of tyrosine aminotransferase in hepatoma cell cultures.
Carcinoma, Hepatocellular
Pretranslational control of tyrosine aminotransferase synthesis by 8-bromo-cyclic AMP in H-4 rat hepatoma cells.
Carcinoma, Hepatocellular
Rat hepatoma cell variants resistant to insulin-diphtheria toxin A fragment conjugates. Genetic evidence for the separate pathways for insulin receptor-mediated mitogenic and hormonal stimulation.
Carcinoma, Hepatocellular
Rat primary hepatocytes and H4 hepatoma cells display differential sensitivity to cyclic AMP at the level of expression of tyrosine aminotransferase.
Carcinoma, Hepatocellular
Regulation of expression of tyrosine aminotransferase in somatic cell hybrids between rat hepatoma cells and mouse fibroblasts.
Carcinoma, Hepatocellular
Regulation of gene expression in rat hepatocytes and hepatoma cells by insulin: quantitation of messenger ribonucleic acid's coding for tyrosine aminotransferase, tryptophan oxygenase, and phosphoenolpyruvate carboxykinase.
Carcinoma, Hepatocellular
Regulation of hepatoma tissue culture cell tyrosine aminotransferase messenger ribonucleic acid by dexamethasone.
Carcinoma, Hepatocellular
Regulation of insulin and insulin-like growth factor (IGF) responsiveness by IGFs in rat hepatoma cells.
Carcinoma, Hepatocellular
Regulation of phosphoenolpyruvate carboxykinase and tyrosine transaminase in hepatoma cell cultures. 3. Comparative studies in H35, HTC, MH1C1 and RLC cells.
Carcinoma, Hepatocellular
Regulation of phosphoenolpyruvate carboxykinase and tyrosine transaminase in hepatoma cell cultures. I. Effects of glucocorticoids, N 6 ,O 2' -dibutyryl cyclic adenosine 3',5'-monophosphate and insulin in Reuber H35 cells.
Carcinoma, Hepatocellular
Regulation of tyrosine aminotransferase by insulin in cultured rat hepatoma cells.
Carcinoma, Hepatocellular
Regulation of tyrosine aminotransferase in rat liver. XI. Studies on the relationship of enzyme stability to enzyme turnover in cultured hepatoma cells.
Carcinoma, Hepatocellular
Regulation of tyrosine aminotransferase synthesis in vitro by mRNA and soluble factors from hepatoma tissue culture cells.
Carcinoma, Hepatocellular
Regulation of urea cycle enzymes in transplantable hepatomas and in the livers of tumor-bearing rats and humans.
Carcinoma, Hepatocellular
Relations between steroid-cell contact, steroid-binding and induction of tyrosine aminotransferase.
Carcinoma, Hepatocellular
Relationship between phosphorylation of tyrosine aminotransferase and regulation of its synthesis by cyclic AMP and hormones.
Carcinoma, Hepatocellular
Selective effect of the metallocarcinogen beryllium on hormonal regulation of gene expression in cultured cells.
Carcinoma, Hepatocellular
Selective inhibition by sodium butyrate of glucocorticoid-induced tyrosine aminotransferase synthesis in hepatoma tissue-cultured cells.
Carcinoma, Hepatocellular
Selectivity of interferon action: hormonal induction of tyrosine aminotransferase in rat hepatoma cells is much less sensitive to interferon than the replication of vesicular stomatitis virus or reovirus.
Carcinoma, Hepatocellular
Somatic cell hybrids between totipotent mouse teratocarcinoma and rat hepatoma cells.
Carcinoma, Hepatocellular
Species-specific differences in the glucocorticoid receptor transactivation function upon binding with betamethasone-esters.
Carcinoma, Hepatocellular
Stimulation of liver functions in hierarchical co-culture of bone marrow cells and hepatocytes.
Carcinoma, Hepatocellular
Studies on the degradation of tyrosine aminotransferase in hepatoma cells in culture. Influence of the composition of the medium and adenosine triphosphate dependence.
Carcinoma, Hepatocellular
Studies on the different molecular forms of tyrosine aminotransferase from rat liver and hepatoma cells.
Carcinoma, Hepatocellular
Superinduction of tyrosine aminotransferase by actinomycin D in rat hepatoma (HTC) cells.
Carcinoma, Hepatocellular
Synthesis and induction of tyrosine aminotransferase in synchronized hepatoma cells in culture.
Carcinoma, Hepatocellular
Synthesis of inducible tyrosine aminotransferase in a cell-free extract from cultured hepatoma cells.
Carcinoma, Hepatocellular
The acute effect of lead acetate on glucocorticoid regulation of tyrosine aminotransferase in hepatoma cells.
Carcinoma, Hepatocellular
The distal enhancer implicated in the developmental regulation of the tyrosine aminotransferase gene is bound by liver-specific and ubiquitous factors.
Carcinoma, Hepatocellular
The effects of metabolic inhibitors on the synthesis of inducible tyrosine aminotransferase in cultured hepatoma cells.
Carcinoma, Hepatocellular
The induction, desensitization and de-induction of tyrosine aminotransferase by 8-bromo-cyclic AMP in rat hepatoma cells.
Carcinoma, Hepatocellular
The influence of culture conditions on the induction of tyrosine aminotransferase by cyclic nucleotides in rat hepatoma cells.
Carcinoma, Hepatocellular
The involvement of cyclic GMP in tyrosine aminotransferase degradation in rat hepatoma tissue culture cells.
Carcinoma, Hepatocellular
The relationship between glucocorticoid binding and tyrosine aminotransferase induction in hepatoma tissue culture cells.
Carcinoma, Hepatocellular
The role of messenger RNA in tyrosine aminotransferase superinduction: effects of camptothecin on hepatoma cells in culture.
Carcinoma, Hepatocellular
The role of transcortin in glucocorticoid mediated enzyme induction: tyrosine aminotransferase induction in hepatoma tissue culture cells.
Carcinoma, Hepatocellular
The stability of tyrosine aminotransferase and other proteins in enucleated rat hepatoma tissue culture cells.
Carcinoma, Hepatocellular
The synergistic interaction of hydrocortisone and dibutyryl cyclic AMP during enzyme induction in hybrids between rat C6 glioma cells and FU5AH hepatoma cells.
Carcinoma, Hepatocellular
Transcriptional and posttranscriptional regulation of tyrosine aminotransferase by insulin in rat hepatoma cells.
Carcinoma, Hepatocellular
Translation of tyrosine aminotransferase mRNA from hepatoma cells in a wheat germ cell-free system.
Carcinoma, Hepatocellular
Transmembrane delivery of polypeptide hormones bypassing the intrinsic cell surface receptors: a conjugate of insulin with alpha 2-macroglobulin (alpha 2M) recognizing both insulin and alpha 2M receptors and its biological activity in relation to endocytic pathways.
Carcinoma, Hepatocellular
Turnover of tyrosine transaminase in cultured hepatoma cells after inhibition of protein synthesis.
Carcinoma, Hepatocellular
Tyrosine aminotransferase sensitivity to bromodeoxyuridine during restricted intervals of S phase in hepatoma cells.
Carcinoma, Hepatocellular
Tyrosine transaminase induction: differential effect of 5-azacytidine on liver and hepatoma 5123D.
Carcinoma, Hepatocellular
Unveiling prognostics biomarkers of tyrosine metabolism reprogramming in liver cancer by cross-platform gene expression analyses.
Carcinoma, Hepatocellular
Variations in some molecular events during the early phases of the reuber H 35 hepatoma cell cycle. I. Glucocorticoid induction of tyrosine aminotransferase.
Carcinoma, Hepatocellular
Variations in some molecular events during the early phases of the Reuber H35 cell cycle. IV-regulation of tyrosine aminotransferase.
Carcinoma, Hepatocellular
Xenobiotics and the glucocorticoid receptor: additive antagonistic effects on tyrosine aminotransferase activity in rat hepatoma cells.
Carcinoma, Hepatocellular
[Activation of transcription of the tyrosine aminotransferase gene in the rat McA-RN 7777 hepatoma cell line by cycloheximide]
Carcinoma, Hepatocellular
[Criteria of the sensitivity of Zajdela and Morris hepatoma cells to glucocorticoids]
Carcinoma, Hepatocellular
[Differences in expression and functional organization of the rat tyrosine aminotransferase gene in two lines of Morris hepatoma, 8994 and 7777]
Carcinoma, Hepatocellular
[Effects of oxidative stress on the proliferation, differentiation and apoptosis in the human hepatoma cells]
Carcinoma, Hepatocellular
[Hormonal induction of tyrosine aminotransferase and RNA synthesis in the cells of Morris hepatoma strain 7777]
Carcinoma, Hepatocellular
[Regulation of the transcription of the tyrosine aminotransferase gene by glucocorticoids in Morris hepatoma 7777 and 8994 cells]
Carcinoma, Hepatocellular
[Use of the tyrosine aminotransferase induction system for the demonstration of the signal effect of glucocorticoid hormones]
Carcinosarcoma
Changes in liver tyrosine-alpha-ketoglutarate transaminase activity during growth of Walker carcinosarcoma 256.
Chagas Disease
Trypanosoma cruzi: characterisation of the gene encoding tyrosine aminotransferase in benznidazole-resistant and susceptible populations.
Cholera
Cyclic AMP responses are suppressed in mammalian cells expressing the yeast low Km cAMP-phosphodiesterase gene.
Diabetes Mellitus
Effects Mifepristone on Aminotransferase Activities in the Liver in Rats with Streptozotocin-Induced Diabetes Mellitus.
Diabetes Mellitus, Experimental
Modification of the pyridoxine-induction of tyrosine transaminase in rat liver by thyroid hormones and by alloxan diabetes.
Diabetes Mellitus, Experimental
[Activity and isoenzymes of tyrosine-alpha-ketoglutarate transaminase in the liver cytostructures of rats with alloxan diabetes. Effect of insulin]
Genetic Diseases, Inborn
Evidence of hippocampal astrogliosis and antioxidant imbalance after L-tyrosine chronic administration in rats.
Glioma
Lipid peroxidation and activities of tyrosine aminotransferase and glutamine synthetase in hepatoma and glioma cells grown in bovine colostrum-supplemented medium.
Glioma
The synergistic interaction of hydrocortisone and dibutyryl cyclic AMP during enzyme induction in hybrids between rat C6 glioma cells and FU5AH hepatoma cells.
Hyperglycemia
Insights into the mechanisms mediating hyperglycemic and stressogenic outcomes in rats treated with monocrotophos, an organophosphorus insecticide.
Hyperglycemia
Resistance training restores metabolic alterations induced by monosodium glutamate in a sex-dependent manner in male and female rats.
Hyperglycemia
Reversible hyperglycemia in rats following acute exposure to acephate, an organophosphorus insecticide: role of gluconeogenesis.
Hypokinesia
The effect of space flight on the board of the satellite Cosmos 2044 on plasma hormone levels and liver enzyme activities of rats.
Infections
Diagnosis of chronic camel trypanosomosis by detection of the antibody of trypanosome tyrosine aminotransferase.
Infections
Diagnosis of trypanosomiasis in experimental mice and field-infected camels by detection of antibody to trypanosome tyrosine aminotransferase.
Infections
Effects of Schistosoma mansoni and Schistosoma japonicum infections on induction of hepatic tyrosine aminotransferase in mice.
Infections
Hormonal regulation of chimeric genes containing the phosphoenolpyruvate carboxykinase promoter regulatory region in hepatoma cells infected by murine retroviruses.
Infections
Increased excretion of aromatic amino acid catabolites in animals infected with Trypanosoma brucei evansi.
Infections
Phenylalanine metabolism in Microtus montanus chronically infected with Trypanosoma brucei gambiense.
Infections
The hepatocyte-specific phenotype of murine liver cells correlates with high expression of connexin32 and connexin26 but very low expression of connexin43.
Intellectual Disability
Molecular biology and molecular pathology of a newly described molecular disease--tyrosinemia II (the Richner-Hanhart syndrome).
Intellectual Disability
TAT gene mutation analysis in three Palestinian kindreds with oculocutaneous tyrosinaemia type II; characterization of a silent exonic transversion that causes complete missplicing by exon 11 skipping.
Intellectual Disability
Tyrosinemia type II: Mutation update, 11 novel mutations and description of 5 independent subjects with a novel founder mutation.
Keratitis
Molecular biology and molecular pathology of a newly described molecular disease--tyrosinemia II (the Richner-Hanhart syndrome).
Keratitis
TAT gene mutation analysis in three Palestinian kindreds with oculocutaneous tyrosinaemia type II; characterization of a silent exonic transversion that causes complete missplicing by exon 11 skipping.
Keratoderma, Palmoplantar
Richner-Hanhart's syndrome: ultrastructural abnormalities of epidermal keratinization indicating a causal relationship to high intracellular tyrosine levels.
Liver Neoplasms
[The glucocorticoid receptors and the induction of tyrosine aminotransferase by glucocorticoid in the human liver cancer cell line (SMMC-7721) in vitro]
Liver Neoplasms, Experimental
Expression of hormonally induced tyrosine aminotransferase in host liver and Morris hepatoma No. 7777 during cofactor depletion.
Liver Neoplasms, Experimental
Further studies on the induction of tyrosine aminotransferase in Morris hepatoma 9618A.
Liver Neoplasms, Experimental
Loss of reciprocal modulations of growth and liver function of hepatoma cells in culture by contact with cells or cell membranes.
Liver Neoplasms, Experimental
Messenger RNA activities for two liver enzymes, tyrosine aminotransferase and tryptophan oxygenase, in Morris hepatoma 5123C and 9618A and in HTC cells. Correlation with enzyme activities.
Liver Neoplasms, Experimental
[Biochemical criteria of mammalian cell sensitivity to glucocorticoids]
Liver Neoplasms, Experimental
[Criteria of the sensitivity of Zajdela and Morris hepatoma cells to glucocorticoids]
Liver Neoplasms, Experimental
[Differences in expression and functional organization of the rat tyrosine aminotransferase gene in two lines of Morris hepatoma, 8994 and 7777]
Liver Neoplasms, Experimental
[Hormonal induction of tyrosine aminotransferase and RNA synthesis in the cells of Morris hepatoma strain 7777]
Liver Neoplasms, Experimental
[Regulation of the transcription of the tyrosine aminotransferase gene by glucocorticoids in Morris hepatoma 7777 and 8994 cells]
Lung Neoplasms
Analysis of co-factor function in a glucocorticoid-resistant small cell carcinoma cell line.
Maple Syrup Urine Disease
The need of essential amino acids in children. An evaluation based on the intake of phenylalanine, tyrosine, leucine, isoleucine, and valine in children with phenylketonuria, tyrosine amino transferase defect, and maple syrup urine disease.
Neoplasms
A glucocorticoid-resistant rat hepatoma cell variant contains functional glucocorticoid receptor.
Neoplasms
Analysis of glucocorticoid-inducible genes in wild-type and variant rat hepatoma cells.
Neoplasms
Apoptosis, redifferentiation and arresting proliferation simultaneously triggered by oxidative stress in human hepatoma cells.
Neoplasms
Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene.
Neoplasms
Control of -aminolevulinic acid synthetase and tyrosine aminotransferase in tumors and livers of tumor-bearing rats.
Neoplasms
Dose-dependent regulation of superoxide anion on the proliferation, differentiation, apoptosis and necrosis of human hepatoma cells: the role of intracellular Ca 2+.
Neoplasms
Effect of pyridoxine on the growth of Morris hepatoma No. 7288Ctc and enzyme activity.
Neoplasms
Effect of trenbolone acetate plus estradiol on transcriptional regulation of metabolism pathways in bovine liver.
Neoplasms
Effects of an antitumoural rhodium complex on thioacetamide-induced liver tumor in rats. Changes in the activities of ornithine decarboxylase, tyrosine aminotransferase and of enzymes involved in fatty acid and glycerolipid synthesis.
Neoplasms
Expressions of hepatic genes, especially IGF-binding protein-1, correlating with serum corticosterone in microarray analysis.
Neoplasms
Glucocorticoids locally disrupt an array of positioned nucleosomes on the rat tyrosine aminotransferase promoter in hepatoma cells.
Neoplasms
Induction of enzymes by glucagon, glucose repression, adenosine 3',5'-monophosphate concentration during carcinogenesis and in Morris 6918A hepatoma.
Neoplasms
Induction of ornithine decarboxylase, tyrosine aminotransferase, and thymidine kinase by glucocorticoid in isolated, perfused liver after tumor inoculation.
Neoplasms
Loss of reciprocal modulations of growth and liver function of hepatoma cells in culture by contact with cells or cell membranes.
Neoplasms
Mutant and wild-type androgen receptors exhibit cross-talk on androgen-, glucocorticoid-, and progesterone-mediated transcription.
Neoplasms
Phorbol myristate acetate (PMA) fails to prevent the appearance of markers associated with muscle and liver differentiation in culture.
Neoplasms
Quantitative differences in androgen and glucocorticoid receptor DNA binding properties contribute to receptor-selective transcriptional regulation.
Neoplasms
Selective activation of the probasin androgen-responsive region by steroid hormones.
Neoplasms
The mechanism for glucocorticoid-resistance in a rat hepatoma cell variant that contains functional glucocorticoid receptor.
Neoplasms
The mechanism of cAMP-induced glucocorticoid receptor expression. Correlation to cellular glucocorticoid response.
Neoplasms
Transfection with steroid-responsive reporter constructs shows glucocorticoid rather than androgen responsiveness in cultured Sertoli cells.
Neoplasms
Transformation of cultured fetal rat liver cells by MDAB and phenobarbital. Morphological, biochemical and immunocytochemical characterization of cell lines.
Neoplasms
[Effect of hepatocarcinogenicity of estragole on the glucocorticoid-mediated induction of liver-specific enzymes and the activity of the transcription factors FOXA and HNF4 in the liver of mouse and rat]
Neurologic Manifestations
Tyrosinemia type II: Mutation update, 11 novel mutations and description of 5 independent subjects with a novel founder mutation.
Otitis
The in vivo glucocorticoid and antiglucocorticoid actions of medroxyprogesterone acetate.
Parasitemia
Diagnosis of trypanosomiasis in experimental mice and field-infected camels by detection of antibody to trypanosome tyrosine aminotransferase.
Phenylketonurias
The need of essential amino acids in children. An evaluation based on the intake of phenylalanine, tyrosine, leucine, isoleucine, and valine in children with phenylketonuria, tyrosine amino transferase defect, and maple syrup urine disease.
Photophobia
Tyrosinemia type II (Richner-Hanhart syndrome): A new mutation in the TAT gene.
Porphyrias
Glucose effect on tryptophan oxygenase and tyrosine aminotransferase induction after allylisopropylacetamide-induced porphyria in the rat.
Porphyrias
Tryptophan pyrrolase, tryptophan and tyrosine transaminase changes during allylisopropylacetamide-induced porphyria in the rat.
Sarcoma, Yoshida
Hormonal effect on tyrosine aminotransferase activities in Yoshida sarcoma and its variant lines.
Schistosomiasis japonica
Effects of Schistosoma mansoni and Schistosoma japonicum infections on induction of hepatic tyrosine aminotransferase in mice.
Sepsis
Endocrine influences on altered hepatic tyrosine transaminase activity during pneumococcal septicemia in the rat.
Starvation
Changes in liver lobule glycogen zonation during prolonged fasting of rats previously fed a 30% casein diet and adapted to a controlled feeding schedule.
Starvation
Correlation of circadian changes in tyrosine aminotransferase and tryptophan-2-3-dioxygenase in rat liver to irradiation at different times of the day.
Starvation
Diurnal variations in response of rat liver tyrosine aminotransferase activity to food intake.
Starvation
Effect of nutritional factors and cortisol on tyrosine aminotransferase activity in liver of brook trout, Salvelinus fontinalis Mitchill.
Starvation
Serine dehydratase and tyrosine aminotransferase activities increased by long-term starvation and recovery by refeeding in rainbow trout (Oncorhynchus mykiss).
Starvation
The influence of starvation and tryptophan administration on the metabolism of phenylalanine, tyrosine and tryptophan in isolated rat liver cells.
Starvation
[The effect of prolonged starvation on changes in the activity of selected adaptive enzymes in rat liver]
Teratocarcinoma
Somatic cell hybrids between totipotent mouse teratocarcinoma and rat hepatoma cells.
Trypanosomiasis
Diagnosis of trypanosomiasis in experimental mice and field-infected camels by detection of antibody to trypanosome tyrosine aminotransferase.
Typhoid Fever
[The effect of lipids from typhoid endotoxin on the activity of some liver enzymes]
tyrosine transaminase deficiency
Creatine and Pyruvate Prevent the Alterations Caused by Tyrosine on Parameters of Oxidative Stress and Enzyme Activities of Phosphoryltransfer Network in Cerebral Cortex of Wistar Rats.
tyrosine transaminase deficiency
Effects of omega-3 fatty acids supplementation on inflammatory parameters after chronic administration of L-tyrosine.
tyrosine transaminase deficiency
Hereditary tyrosinaemia type II in a consanguineous Ashkenazi Jewish family: intrafamilial variation in phenotype; absence of parental phenotype effects on the fetus.
tyrosine transaminase deficiency
Herpetiform keratitis and palmoplantar hyperkeratosis: warning signs for Richner-Hanhart syndrome.
tyrosine transaminase deficiency
Response of the lysosomal system of the corneal epithelium to tyrosine-induced cell injury.
tyrosine transaminase deficiency
Richner-Hanhart syndrome (tyrosinemia type II). Case report and literature review.
tyrosine transaminase deficiency
Role of antioxidant treatment on DNA and lipid damage in the brain of rats subjected to a chemically induced chronic model of tyrosinemia type II.
tyrosine transaminase deficiency
Soluble tyrosine aminotransferase deficiency: an unusual cause of corneal ulcers.
tyrosine transaminase deficiency
The origin of urinary p-hydroxyphenylpyruvate in a patient with hepatic cytosol tyrosine aminotransferase deficiency.
tyrosine transaminase deficiency
Tyrosine aminotransferase deficiency in mink (Mustela vision): a model for human tyrosinemia II.
Tyrosinemias
Acute administration of l-tyrosine alters energetic metabolism of hippocampus and striatum of infant rats.
Tyrosinemias
Antioxidants reverse the changes in energy metabolism of rat brain after chronic administration of L.-tyrosine.
Tyrosinemias
Antioxidants Reverse the Changes in the Cholinergic System Caused by L-Tyrosine Administration in Rats.
Tyrosinemias
Comparison of the tyrosine aminotransferase cDNA and genomic DNA sequences of normal mink and mink affected with tyrosinemia type II.
Tyrosinemias
Creatine and Pyruvate Prevent the Alterations Caused by Tyrosine on Parameters of Oxidative Stress and Enzyme Activities of Phosphoryltransfer Network in Cerebral Cortex of Wistar Rats.
Tyrosinemias
Defect in soluble tyrosine aminotransferase in skin fibroblasts of a patient with tyrosinemia.
Tyrosinemias
Effect of acute administration of L-tyrosine on oxidative stress parameters in brain of young rats.
Tyrosinemias
Effects of omega-3 fatty acids supplementation on inflammatory parameters after chronic administration of L-tyrosine.
Tyrosinemias
Evidence of hippocampal astrogliosis and antioxidant imbalance after L-tyrosine chronic administration in rats.
Tyrosinemias
Hereditary tyrosinaemia type II in a consanguineous Ashkenazi Jewish family: intrafamilial variation in phenotype; absence of parental phenotype effects on the fetus.
Tyrosinemias
Herpetiform keratitis and palmoplantar hyperkeratosis: warning signs for Richner-Hanhart syndrome.
Tyrosinemias
Inherited and de novo deletion of the tyrosine aminotransferase gene locus at 16q22.1----q22.3 in a patient with tyrosinemia type II.
Tyrosinemias
New forms of hereditary tyrosinemia type II in mink: hepatic tyrosine aminotransferase defect.
Tyrosinemias
Novel and recurrent tyrosine aminotransferase gene mutations in tyrosinemia type II.
Tyrosinemias
Omega-3 fatty acid supplementation can prevent changes in mitochondrial energy metabolism and oxidative stress caused by chronic administration of L-tyrosine in the brain of rats.
Tyrosinemias
Omega-3 fatty acid supplementation decreases DNA damage in brain of rats subjected to a chemically induced chronic model of Tyrosinemia type II.
Tyrosinemias
Persistent tyrosinemia associated with low activity of tyrosine aminotransferase.
Tyrosinemias
Response of the lysosomal system of the corneal epithelium to tyrosine-induced cell injury.
Tyrosinemias
Richner-Hanhart syndrome (tyrosinemia type II). Case report and literature review.
Tyrosinemias
Richner-Hanhart syndrome (tyrosinemia type II): a case report of delayed diagnosis with pseudodendritic corneal lesion.
Tyrosinemias
Richner-Hanhart syndrome: report of a case with a novel mutation of tyrosine aminotransferase.
Tyrosinemias
Role of antioxidant treatment on DNA and lipid damage in the brain of rats subjected to a chemically induced chronic model of tyrosinemia type II.
Tyrosinemias
Soluble and mitochondrial forms of tyrosine aminotransferase. Relationship to human tyrosinemia.
Tyrosinemias
Soluble tyrosine aminotransferase deficiency: an unusual cause of corneal ulcers.
Tyrosinemias
The effect of a low-protein diet and dietary supplementation of threonine on tyrosine and 2-(2-nitro-4-trifluoromethylbenzoyl) cyclohexane-1,3-dione-induced corneal lesions, the extent of tyrosinemia, and the activity of enzymes involved in tyrosine catabolism in the rat.
Tyrosinemias
The human tyrosine aminotransferase gene: characterization of restriction fragment length polymorphisms and haplotype analysis in a family with tyrosinemia type II.
Tyrosinemias
The narrow substrate specificity of human tyrosine aminotransferase--the enzyme deficient in tyrosinemia type II.
Tyrosinemias
The origin of urinary p-hydroxyphenylpyruvate in a patient with hepatic cytosol tyrosine aminotransferase deficiency.
Tyrosinemias
Tissue distribution of 2-(2-nitro-4-trifluoromethylbenzoyl)cyclohexane-1-3-dione (NTBC): effect on enzymes involved in tyrosine catabolism and relevance to ocular toxicity in the rat.
Tyrosinemias
Tyrosine administration decreases glutathione and stimulates lipid and protein oxidation in rat cerebral cortex.
Tyrosinemias
Tyrosine aminotransferase deficiency in mink (Mustela vision): a model for human tyrosinemia II.
Tyrosinemias
Tyrosinemia type II (Richner-Hanhart syndrome): A new mutation in the TAT gene.
Tyrosinemias
Tyrosinemia type II: Mutation update, 11 novel mutations and description of 5 independent subjects with a novel founder mutation.
Tyrosinemias
Tyrosinemia type II: Novel mutations in TAT in a boy with unusual presentation.
Tyrosinemias
[Oculo-cutaneous tyrosinosis (Richner-Hanhart syndrome). Histo-pathological study of a case]
Uremia
Translocation of inducible tyrosine aminotransferase to the mitochondrial fraction. Facilitation by acute uremia and other conditions.
Vesicular Stomatitis
Selectivity of interferon action: hormonal induction of tyrosine aminotransferase in rat hepatoma cells is much less sensitive to interferon than the replication of vesicular stomatitis virus or reovirus.
Vitamin B 12 Deficiency
Vitamin B12 deficiency results in the abnormal regulation of serine dehydratase and tyrosine aminotransferase activities correlated with impairment of the adenylyl cyclase system in rat liver.
Vitamin B 6 Deficiency
Effect of pyridoxine deficiency on tyrosine transaminase activity and growth of four Morris hepatomas.
Vitamin B 6 Deficiency
Pyridoxal 5' phosphate involvement in age-related modifications of tyrosine aminotransferase: multiple form patterns.
Vitamin B 6 Deficiency
The effect of pyridoxine deficiency on L-aromatic amino acid decarboxylase and tyrosine aminotransferase in developing brain.
html completed